Evidence map›Paper›PMID 30999960›Full record

ArticleParasites & vectors2019

Dirofilaria repens in dogs and humans in Lithuania.

Vytautas Sabūnas, Jana Radzijevskaja, Povilas Sakalauskas, Saulius Petkevičius, Birutė Karvelienė, Jolanta Žiliukienė, Indrė Lipatova, Algimantas Paulauskas

Abstract read
In one paragraph

Article in Parasites & vectors, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Detection ofTransboundary and emerging diseases · 2025
    Article
  6. Article
  7. A Rare Case of Dirofilariasis in the Genian Region.Diagnostics (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. Journal of veterinary research · 2022
    Article
  11. Molecular prevalence ofVeterinary world · 2022
    Article
  12. One health (Amsterdam, Netherlands) · 2021
    Review
  13. Emergence ofVeterinary world · 2021
    Article
  14. Pathogens (Basel, Switzerland) · 2021
    Review
  15. Article
  16. Immunoproteomic Analysis ofPathogens (Basel, Switzerland) · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Vytautas SabūnasDepartment of Biology, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos str. 8, LT-44404, Kaunas, Lithuania.
Jana RadzijevskajaDepartment of Biology, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos str. 8, LT-44404, Kaunas, Lithuania.
Povilas SakalauskasDepartment of Biology, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos str. 8, LT-44404, Kaunas, Lithuania.
Saulius PetkevičiusDepartment of Veterinary Pathobiology, Veterinary Academy, Lithuanian University of Health Sciences, Tilžės str. 18, 47181, Kaunas, Lithuania.
Birutė KarvelienėDepartment of Veterinary Pathobiology, Veterinary Academy, Lithuanian University of Health Sciences, Tilžės str. 18, 47181, Kaunas, Lithuania.
Jolanta ŽiliukienėNational Public Health Surveillance Laboratory, Žolyno str. 36, 10210, Vilnius, Lithuania.
Indrė LipatovaDepartment of Biology, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos str. 8, LT-44404, Kaunas, Lithuania.
Algimantas PaulauskasDepartment of Biology, Faculty of Natural Sciences, Vytautas Magnus University, Vileikos str. 8, LT-44404, Kaunas, Lithuania. algimantas.paulauskas@vdu.lt.

Funding

Lietuvos Mokslo Taryba (LT) VP1-3.1-ŠMM-01-V-02-003
6 · The paper itself

Abstract

backgroundIn Lithuania, the first case of canine subcutaneous dirofilariosis was recorded in 2010. Since then, an increasing number of cases of canine dirofilariosis have been documented in different veterinary clinics throughout the country. Human dirofilariosis was diagnosed in Lithuania for the first time in September 2011. However, to the authors' knowledge, there are no published data on the presence and prevalence of autochthonous dirofilariosis in dogs and humans in the country. The present study provides information about the predominant species and prevalence of Dirofilaria in dogs and describes the cases of human dirofilariosis in Lithuania. It also outlines PCR detection of the bacterial endosymbiont Wolbachia that contributes to the inflammatory features of filarioid infection.

resultsA total of 2280 blood samples and six adult worms from pet and shelter dogs were collected in the central and eastern regions of Lithuania in 2013-2015. Based on their morphological appearance, morphometric measurements and molecular analysis, all the adult nematodes were identified as Dirofilaria repens. The diagnosis of microfilariae in blood samples was based on blood smear analysis and Knott's test. The PCR and sequence analysis of the ribosomal DNA ITS2 region and cox1 gene confirmed the presence of D. repens. Overall, 61 (2.7%) of the 2280 blood samples were found to be positive for the presence of D. repens. The infection rate of D. repens was significantly higher in shelter dogs (19.0%; 19/100) than in pet dogs (1.9%; 42/2180) (χ

conclusionsTo the authors' knowledge, this is the first report of autochthonous D. repens infection in dogs and humans in Lithuania. The present data demonstrate that D. repens is the main etiological agent of dirofilariosis in Lithuania. The DNA of the filarioid endosymbiotic bacterium Wolbachia was detected in the vast majority of dogs infected with D. repens.

Indexed as

Dirofilaria repensAdultAgedAnimalsChildDirofilariasisDog DiseasesDogsEye DiseasesFemaleHumansLithuaniaMaleMiddle AgedPhylogenyPolymerase Chain ReactionAutochthonousDirofilaria repensDirofilariosisDogsHumansLithuaniaWolbachia

Identifiers

PMID30999960
PMCPMC6472076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.